These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8147937)

  • 1. Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.
    Chariot P; Monnet I; Mouchet M; Rohr M; Lefaucheur JP; Dubreuil-Lemaire ML; Chousterman M; Gherardi R
    Arthritis Rheum; 1994 Apr; 37(4):583-6. PubMed ID: 8147937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia.
    Dengler R; Wohlfarth K; Zierz S; Jobges M; Schubert M
    Muscle Nerve; 1996 Apr; 19(4):456-62. PubMed ID: 8622724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine-associated myopathy.
    Paradis J; Calis KA
    Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV or zidovudine myopathy?
    Dalakas M
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV or zidovudine myopathy?
    Grau JM; Casademont J
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract]   [Full Text] [Related]  

  • 11. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
    Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
    Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 14. Turns-amplitude analysis assessment of myopathies in HIV-infected patients.
    Lefaucheur JP; Verroust J; Gherardi RK
    J Neurol Sci; 1996 Mar; 136(1-2):148-53. PubMed ID: 8815162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
    Gherardi RK; Florea-Strat A; Fromont G; Poron F; Sabourin JC; Authier J
    Ann Neurol; 1994 Nov; 36(5):752-8. PubMed ID: 7979221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate stress test in the diagnosis of mitochondrial myopathy.
    Finsterer J; Shorny S; Capek J; Cerny-Zacharias C; Pelzl B; Messner R; Bittner RE; Mamoli B
    J Neurol Sci; 1998 Aug; 159(2):176-80. PubMed ID: 9741404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, histological and molecular reversibility of zidovudine myopathy.
    Masanés F; Barrientos A; Cebrián M; Pedrol E; Miró O; Casademont J; Grau JM
    J Neurol Sci; 1998 Aug; 159(2):226-8. PubMed ID: 9741412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal handling of blood samples for routine measurement of lactate and pyruvate.
    Chariot P; Ratiney R; Ammi-Said M; Hérigault R; Adnot S; Gherardi R
    Arch Pathol Lab Med; 1994 Jul; 118(7):695-7. PubMed ID: 8024401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitochondrial myopathy with increased blood lactate and pyruvate levels among siblings in familial thiamine deficiency].
    Sato Y; Kaji M; Osame M; Matsuishi T; Itokawa Y
    Rinsho Shinkeigaku; 1983 Aug; 23(8):668-77. PubMed ID: 6661867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.